Prime Capital Investment Advisors’s Allergan plc AGN Stock Holding History

Prime Capital Investment Advisors’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-111	Closed	-$21K	–	671
2019 Q4	$21K	Hold	111	–	–	﹤0.01%	406
2019 Q3	$19K	Buy	+111	New	+$18.1K	﹤0.01%	429
2019 Q1	–	Sell	-9	Closed	-$1K	–	488
2018 Q4	$1K	Sell	9 -16	-64%	-$2.62K	﹤0.01%	353
2018 Q3	$5K	Buy	+25	New	+$4.59K	﹤0.01%	243
2018 Q1	–	Sell	-11	Closed	-$2K	–	288
2017 Q4	$2K	Buy	+11	New	+$1.97K	﹤0.01%	242

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prime Capital Investment Advisors's AGN Position: Q1 2020 in Review

Prime Capital Investment Advisors sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 111 shares — an estimated $21K sold.

Prime Capital Investment Advisors first reported a position in AGN in Q4 2017 and held it in 5 quarters. The position peaked at $21K in Q4 2019. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

Prime Capital Investment Advisors reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
Prime Capital Investment Advisors sold 111 Allergan plc shares in Q1 2020, an estimated $21K.
Prime Capital Investment Advisors first reported a position in Allergan plc in Q4 2017 and held it in 5 quarters.
Prime Capital Investment Advisors's Allergan plc position peaked at $21K in Q4 2019.
876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Prime Capital Investment Advisors's 13F filing for Q1 2020, filed 4 May 2020.